Reilly Financial Advisors LLC lowered its position in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) by 5.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,890 shares of the company’s stock after selling 1,545 shares during the quarter. Reilly Financial Advisors LLC owned approximately 0.33% of Invesco Dynamic Pharmaceuticals ETF worth $1,903,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of PJP. Jane Street Group LLC boosted its stake in Invesco Dynamic Pharmaceuticals ETF by 25.5% in the first quarter. Jane Street Group LLC now owns 32,840 shares of the company’s stock worth $2,049,000 after buying an additional 6,675 shares in the last quarter. CIBC World Markets Inc. purchased a new stake in Invesco Dynamic Pharmaceuticals ETF in the first quarter worth approximately $365,000. Cornerstone Wealth Management LLC purchased a new stake in Invesco Dynamic Pharmaceuticals ETF in the second quarter worth approximately $934,000. Kiley Juergens Wealth Management LLC purchased a new stake in Invesco Dynamic Pharmaceuticals ETF in the second quarter worth approximately $112,000. Finally, Madison Investment Holdings Inc. boosted its stake in Invesco Dynamic Pharmaceuticals ETF by 26.6% in the second quarter. Madison Investment Holdings Inc. now owns 41,069 shares of the company’s stock worth $2,760,000 after buying an additional 8,627 shares in the last quarter.
Shares of NYSEARCA:PJP traded down $0.18 during trading on Friday, reaching $69.52. 2,226 shares of the company traded hands, compared to its average volume of 41,140. Invesco Dynamic Pharmaceuticals ETF has a 52-week low of $59.82 and a 52-week high of $74.29.
About Invesco Dynamic Pharmaceuticals ETF
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Featured Story: Understanding Price to Earnings Ratio (PE)
Receive News & Ratings for Invesco Dynamic Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.